You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-p95 NBS1 (phospho S343) antibody (ab47272)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab47272? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab47272 has been referenced in 3 publications.

  1. Horton JK et al. Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition. DNA Repair (Amst) 10:225-34 (2011). WB; Human. PubMed: 21130714
  2. Reiman A et al. Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br J Cancer 105:586-91 (2011). WB; Human. PubMed: 21792198
  3. Weston VJ et al. The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Blood 116:4578-87 (2010). WB; Human. PubMed: 20739657

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"